One month after Tesla lost its head of business development who wished to “spend more time with his family”, and just weeks after the EV company’s veteran battery technology director also unexpectedly quit amid a growing senior management exodus (full list at the bottom
October 14, 2017
Shanghai Pharma (SHA: 601607) and FountainVest Partners, a China private equity fund, have submitted second-round bids for Cardinal China’s (NYSE: CAH) drug distribution operations (see story). According to a Bloomberg article, the two entities are part of a smaller group of still-interested bidders